Elsevier,
The Lancet Healthy Longevity, Volume 4, May 2023
This Article supports SDG 3 by comparing epigenetic ageing during untreated HIV infection and during HIV being treated with antiretroviral therapy. They found that epigenetic ageing was accelarated during the former and decelerated during the latter.
Elsevier,
The Lancet Regional Health - Europe, Volume 28, May 2023
This Article supports SDG 3 by evaluating the effects of a behavioural intersectional stigma coping intervention on stigma and care use. They found that the brief intervention did not change stigma manifestations or drug use behaviours but did reduce the impact of stigma as a barrier to care use.
Elsevier,
Cell Chemical Biology, Volume 30, 18 May 2023
Richard et al. provide extensive evidence suggesting that treatment with the HIV-1 attachment inhibitor temsavir can have beneficial effects that extend beyond viral neutralization, notably by preventing elimination of uninfected cells and induction of a cytokine burst caused by its soluble viral glycoprotein.
Elsevier,
The Lancet HIV, Volume 10, May 2023
This Article supports SDG 3 by analysing follow-up data from over 200 000 people with HIV from 20 cohorts in North America and Europe who had started ART up to 20 years previously, and showing that estimated life expectancy for people with HIV on long-term ART with high CD4 cell counts is only a few years lower than that in the general population, irrespective of when ART was started.
Elsevier,
Heliyon, Volume 9, May 2023
This study assessed the central auditory processing (CAP) function and its electroencephalogram (EEG) in patients with mild cognitive impairment (MCI) and the early stage of Alzheimer's disease (AD) so as to provide a basis for early recognition and intervention of AD.
Elsevier,
eClinicalMedicine, Volume 59, May 2023
In this follow-up study, virological response to and adverse event profile of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) was assessed at 240 weeks. >98% of people with HIV who received B/F/TAF maintained an HIV-1 RNA of <50 copies/mL, with no treatment-emergent resitance reported. The longevity of B/F/TAF action and participant responses is shown after 5 years of follow-up.
Elsevier,
Current Biology, Volume 33, 8 May 2023
This article links with the United Nations Sustainable Development Goals (SDGs) by addressing Goal 11 (Sustainable Cities and Communities) and Goal 15 (Life on Land), as it examines how urbanization affects biodiversity and the traits that enable bird species to adapt to urban environments. By developing a predictive framework for urban tolerance, the research contributes to conservation efforts aimed at preserving biodiversity in increasingly urbanized landscapes, thereby promoting sustainable coexistence between human populations and wildlife.
